| Identification | |
| Name: | 2,4-Thiazolidinedione,5-[[4-[(1-methylcyclohexyl)methoxy]phenyl]methyl]- |
| Synonyms: | ADD 3878;Ciglitazone;U 63287; |
| CAS: | 74772-77-3 |
| Molecular Formula: | C18H23NO3S |
| Molecular Weight: | 333.4451 |
| InChI: | InChI=1/C18H23NO3S/c1-18(9-3-2-4-10-18)12-22-14-7-5-13(6-8-14)11-15-16(20)19-17(21)23-15/h5-8,15H,2-4,9-12H2,1H3,(H,19,20,21) |
| Molecular Structure: |  |
| Properties | |
| Density: | 1.189 g/cm3 |
| Refractive index: | 1.568 |
| Appearance: | white cyrstalline solid |
| Specification: | White Cyrstalline Solid usageEng:Displays antihyperglycemic activity in genetically obese mice. It is a selective PPARg agonist |
| Biological Activity: | Selective agonist at PPAR γ (peroxisome proliferator-activated receptor γ ). Activates PPAR γ with an EC 50 value of 3 μ M in vitro , and is at least 33-fold selective over PPAR α and δ . Antihyperglycemic in vivo . |
| Storage Temperature: | Store at RT |
| Usage: | Displays antihyperglycemic activity in genetically obese mice. It is a selective PPARg agonist |
| Safety Data | |
 |
|
